Cross-sectional analysis identifies clinical and demographic factors influencing GLP-1RA eligibility in youth, suggesting important treatment considerations.
This cross-sectional study describes demographic, clinical, and socioeconomic characteristics of US adolescents and young adults who are eligible to receive glucagon-like peptide-1 receptor agonists (GLP-1RAs).
No takes yet. Share an insight, caveat, or question.
Chetty et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: